Skip to main content

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients

Treatment of Radiation and Cisplatin Induced Toxicities With Tempol

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Treatment of Radiation and Cisplatin Induced Toxicities With Tempol

Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma

Surveillance HeartCare® Outcomes Registry

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Surveillance HeartCare® Outcomes Registry

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)

ASSIST Registry Studying Various Operator Techniques

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about ASSIST Registry Studying Various Operator Techniques

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • Page 215
  • …
  • Next page Next
  • Last page Last
Subscribe to